FibroGen (FGEN) Misses Q3 EPS by 15c

November 8, 2018 4:44 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.50), $0.15 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $29.03 million versus the consensus estimate of $36.48 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings